Shanghai Sanyou Medical (688085) 证券之星·2025-03-26 13:14Core Viewpoint - The company announced adjustments to the internal investment structure of certain fundraising projects and the postponement of the "Medical High-Strength Suture and Related Orthopedic Soft Tissue Repair Reconstruction Medical Device Project" to December 31, 2027, without changing the overall direction, total investment amount, functionality, or implementation entity of the fundraising projects [1][6]. Fundraising Basic Situation - The company was approved to publicly issue 51,333,500 shares at a price of RMB 20.96 per share, raising a total of RMB 1,075,950,160, with net proceeds of RMB 978,057,381.28 after deducting issuance costs [1][2]. Fundraising Investment Projects - The total investment for the fundraising projects is RMB 62,200,000, with a committed investment amount of RMB 60,000,000 [3]. Internal Structure Adjustment and Postponement - The internal structure adjustment of the fundraising project involves reducing certain personnel costs and research expenses while increasing construction costs. The total investment remains at RMB 4,500,000 [4][5]. - The project timeline has been extended from March 2025 to December 2027 due to delays in construction, product registration, and other factors [6][7]. Necessity and Feasibility of Project Implementation - The project is necessary due to the limited suppliers in the domestic orthopedic sports medicine field and the need for customized equipment from overseas, which has caused delays [7]. - The company has established a robust research and development system in the field of sports medicine and has already made significant investments in funding, equipment, and personnel, ensuring the feasibility of the project [7][8]. Review Procedures - The adjustments were approved by the company's board and supervisory committee, and the sponsor institution confirmed that the necessary decision-making procedures were followed, with no need for shareholder meeting approval [8][9].